Wing Chan

Wing Chan has over two decades of work experience in various roles related to business analytics, market research, and strategic planning. They began their career at Capital One as an Analyst, working on cross-selling initiatives from 2000 to 2003. Wing then moved to Merck & Co., where they held a role in information management, strategic planning, market research, and analytics from 2003 to 2012. After that, they joined sanofi-aventis as a Senior Manager in MR, Oncology, staying with the company until 2013. At Bayer HealthCare, Wing served as an Associate Director from 2013 to 2015 before joining Lexicon Pharmaceuticals, Inc. as the Director of Marketing Analytics. They worked at Lexicon Pharmaceuticals until 2019 when they transitioned to Intra-Cellular Therapies as the Senior Director of Business Insights & Analytics. Currently, Wing is working at Stemline Therapeutics as the AVP of the Digital & Business Analytics Center of Excellence, starting in 2022.

Wing Chan completed a Bachelor of Science degree in Management Information Systems and Services at Penn State University from 1997 to 2000. Later, from 2003 to 2006, they pursued a Master of Science degree in Statistics at Colorado State University. Lastly, from 2008 to 2011, Wing Chan obtained their M.B.A. degree from New York University.